Steinert's myotonic dystrophy - Symptoms, diagnosis and treatment
DM1 pathogenetic mechanisms and therapeutic strategies. The actions of... | Download Scientific Diagram
IJMS | Free Full-Text | Epigenetics of Myotonic Dystrophies: A Minireview
Cardiovascular manifestations of Myotonic Dystrophy
Epigenetics and Myotonic Dystrophy Type 1 | Encyclopedia MDPI
RNA toxicity model for DM1 pathogenesis and potential therapeutic... | Download Scientific Diagram
Aberrant Expression of a Non-muscle RBFOX2 Isoform Triggers Cardiac Conduction Defects in Myotonic Dystrophy - ScienceDirect
IJMS | Free Full-Text | Disrupting the Molecular Pathway in Myotonic Dystrophy
W David Arnold - Myotonic Dystrophy Overview and Update
Time-controlled and muscle-specific CRISPR/Cas9-mediated deletion of CTG-repeat expansion in the DMPK gene: Molecular Therapy - Nucleic Acids
Projects
DM1-AS Gene - GeneCards | DM1-AS RNA Gene
Gene Therapy and Gene Editing for Myotonic Dystrophy | SpringerLink
Molecular genetics of congenital myotonic dystrophy - ScienceDirect
Additional molecular pathogenetic mechanisms in DM1. Results suggest an... | Download Scientific Diagram
Entrada Therapeutics | Myotonic Dystrophy Type 1 (DM1)
Myotonic dystrophy - Wikipedia
Myopathies without EOM Weakness: Facioscapulohumeral + Myotonic Dystrophy
Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2 | European Journal of Human Genetics
Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells: Molecular Therapy - Nucleic Acids
Frontiers | Muscle wasting in myotonic dystrophies: a model of premature aging
